strated that Mus81-Eme1 could cleave Holliday junctions in a purified system. Mutants lacking this enzyme had a profound meiotic crossover defect that could be rescued by expression of a bacterial Holliday junction cleaving enzyme. Cromie et al. (2006) now show that mus81 mutants accumulate Holliday junctions. Combined with earlier observations in budding yeast (de los Santos et al., 2003) , the fission yeast studies suggest that not only do the predominant DNA intermediates differ between species, but the enzymes most important for resolving those intermediates may differ as well.
Differences in the recombination mechanisms between fission and budding yeast argue against a reductionist approach to describing the mechanism, even within a single organism. Indeed, a number of studies indicate that not all recombination occurs via the canonical double-strand break repair mechanism, even in budding yeast (Merker et al., 2003; Allers and Lichten, 2001 and references therein). Of particular note is work suggesting that most noncrossover recombinants form by a mechanism that does not include a Holliday junction intermediate ( Figure 1C ) (Allers and Lichten, 2001) .
Thus, it appears that individual meiotic recombination events proceed via different mechanisms within an organism and that the prevalent mechanism can differ between organisms. What controls progression on one pathway versus another? Does pathway prevalence vary from one locus to the next, and, if so, why? Do different pathways contribute distinct biological or evolutionary functions? Can distinguishing features of the various pathways give us clues about mechanisms of regulation? For example, are double Holliday junctions essential for crossover control? Answering these questions requires development of better assays for diagnostic features of each pathway at a given locus as well as examination of additional loci in each organism. Finally, the new study emphasizes the need to characterize recombination intermediates in beasts other than yeasts. The initial factors that trigger the autoimmune response against pancreatic islets in the nonobese diabetic (NOD) mouse are still unknown. In this issue of Cell, Razavi et al. (2006) propose that a defect in a subset of sensory neurons innervating the pancreas plays a major role in initiating the chain of events that will lead to local inflammation, islet destruction, and autoimmune diabetes.
to the development of autoimmune diabetes, the precise etiology and the initiating factors that trigger the autoimmune response against pancreatic islets are still unknown. In this issue, Razavi et al. (2006) propose that a defect in sensory neurons innervating the pancreas contribute to insulin resistance and β cell stress in NOD mice by initiating local inflammation and an autoimmune attack on pancreatic islets. These results suggest a clear link between autoimmunity, inflammation, and the nervous system. However, is the link between the nervous system and autoimmunity an epiphenomenon, or is there a direct link between autoantigenic determinants shared by these intertwined tissues? Pancreatic islets are innervated by a network of primary sensory afferent neurons, a subset of which expresses the capsaicin receptor TRPV1 (transient receptor potential vanilloid-1). Razavi et al. (2006) describe two mutations in conserved regions of the trpv1 gene in NOD mice and propose trpv1 as a candidate gene for the diabetes susceptibility locus Idd4.1 on chromosome 11. TRPV1 polymorphism in NOD mice was associated with functional defects in neurons expressing TRPV1, including reduced secretion of substance P from pancreatic nerve terminals. Importantly, restoration of this function in congenic NOD mice expressing the B6 TRPV1 allele or by local administration of substance P led to reduced autoreactive T cell proliferation, islet infiltration, and diabetes. Thus, the authors suggest that a molecular defect in the pancreatic innervation system could dramatically affect autoimmune diabetes. However, previous studies have shown that the Idd4 locus does not provide complete protection from insulitis and diabetes, suggesting that the neuronal defect identified by the authors does not fully account for the initiation of the autoimmune process in NOD mice.
The multiple interactions between neuronal and endocrine functions led to the concept of an integrated neuroendocrine system. Intriguingly, the demonstration that insulin-producing cells found in the brain of the fruit fly Drosophila are functionally analogous to pancreatic islet β cells led Rulifson et al. (2002) to hypothesize the existence of a common ancestral insulin-producing organ of neural origin. The Razavi et al. (2006) study raises the possibility that signals delivered by the nervous system can alter inflammation and insulin resistance and thus "indirectly" affect the development of the autoimmunity. However, an equally plausible possibility is that an autoimmune component targeting the nervous system directly influences the development of autoreactive responses against pancreatic islets. A high percentage of diabetic individuals in Sardinia and Canada have multiple sclerosis-an autoimmune T cell-mediated demyelinating process. Furthermore, Dosch and colleagues reported T cell responses and autoantibodies directed at neural cell antigens expressed in the central nervous system or in the peripheral nervous system in patients with type 1 diabetes (Winer et al., 2001; Winer et al., 2003) . In fact, many proteins thought to play a role in type 1 diabetes have an expression pattern limited to the pancreas and the nervous system. Finally, autoimmune responses targeting the nervous system have been described in the NOD mouse. Blocking the costimulatory CD28/B7-2 or IL-2 pathways in NOD mice resulted in the development of an autoimmune peripheral neuropathy (Salomon et al., 2001; Setoguchi et al., 2005) . In addition, T cell responses and autoantibodies directed at peri-islet Schwann cells and other neural structures in the pancreas were found in the NOD mouse. Moreover, this autoimmune response targeted neural antigens shared with islets such as glutamic acid decarboxylase (GAD65) as well as Schwann cell proteins such as S100β and glial fibrillary acidic protein (GFAP) (Winer et al., 2001; Winer et al., 2003) . Finally, Dosch and colleagues have argued that responses against neural elements play an important role in "initiating" autoreactive responses against islets. Winer et al. (2003) showed that the insulitis that precedes overt clini- In normal mice (not shown), a feedback loop involving islet β cells and sensory neurons expressing TRPV1 maintains balanced levels of insulin and substance P. In NOD mice, insulin secretion by islet β cells fails to properly stimulate the sensory neurons expressing TRPV1 to release neuropeptides due to the presence of a hypofunctional polymorphism in the trpv1 gene. Suboptimal local levels of neuropeptides lead to insulin resistance and β cell stress as well as a local proinflammatory milieu, while physiological cell death of neurons and islet β cells leads to the presentation of auto-antigens by professional antigen-presenting cells (APCs) in draining lymph nodes. Infiltration of Schwann cell and islet-specific T cells is sustained by the local proinflammatory milieu resulting from defective TRPV1 signals in sensory neurons.
cal diabetes may be, in part, directed against immature Schwann cells surrounding pancreatic islets. Furthermore, T cell lines specific for GFAP promote insulitis, whereas antigenbased therapy inhibits diabetes. Dosch and colleagues now extend their model to propose that defects in TRPV1 + neuron function, particularly the reduced release of substance P, are directly linked to the mild hyperinsulinemia and insulin resistance that have been previously described in young NOD mice (reviewed in HomoDelarche, 2004 ) and lead to β cell stress. Surprisingly, the removal of neurons expressing TRPV1 by neonatal capsaicin treatment resulted in a similar outcome on anti-islet autoimmunity as restoration of their function. Razavi et al. (2006) explain this paradox by a model in which only subnormal local levels of neuropeptides are pathogenic and lead to β cell stress and inflammation. Although neuropeptides can have opposite physiological effects at different concentrations, it will remain to be confirmed whether complete elimination of neurons expressing TRPV1 affects diabetes through distinct pathways, such as antigen removal or increased regulatory T cells as shown by Razavi et al. (2006) .
The authors propose that together with reduced local levels of substance P, which has anti-inflammatory effects, β cell stress contributes to the recruitment of mononuclear cells that marks the beginning of the autoimmune process against NOD islets (Razavi et al., 2006) . Indeed, insulin resistance was abrogated in NOD-B6-Idd4 congenic mice or after local administration of substance P in NOD mice. This mechanism may not be limited to substance P as the transgenic expression in pancreatic islets of calcitonin gene-related peptide (CGRP), another neuropeptide that has immunosuppressive properties and is released by sensory neurons, resulted in reduced diabetes incidence in NOD mice (Khachatryan et al., 1997) . From a kinetic standpoint, it is remarkable that physiological cell death of both neurons and islet β cells occurs shortly after birth in all strains of mice and may lead to the presentation of autoantigens by professional antigen-presenting cells in draining lymph nodes. Thus, the precise timing of antigen release and presentation and of local inflammation secondary to neuronal defects may determine whether initial autoreactive T cell responses are directed against islet or neural antigens. Importantly, the defective feedback loop between neurons expressing TRPV1 and β cells was observed in immunodeficient NOD (NOD-SCID) mice as well, supporting the hypothesis that it may initiate local inflammation rather than be a consequence of it. Furthermore, there are patients with a complex form of diabetes with unexplained combinations of syndromes from types 1 (autoimmunity) and 2 (insulin resistance). These are sometimes referred to as "type 1-1/2" and have some characteristics consistent with the syndromes described by Razavi et al. (2006) . Interestingly, abnormal β cell function has also been described in NOD mice and was believed to be secondary to high levels of inflammatory mediators during the autoimmune process. However, recent data by Chaparro et al. (2006) identify intrinsic alterations of pancreas physiology in the absence of autoimmune responses in NOD-SCID mice, including ER protein stress and insulin resistance. The findings by Razavi et al. (2006) possibly link these parameters commonly associated with type 2 diabetes to abnormal sensory neuron function in NOD mice. Conversely, insulin resistance and β cell stress have been described in mouse models that do not develop autoimmune diabetes. Thus, the findings presented by Dosch and colleagues ought to be put in the context of other defects in central and peripheral tolerance afflicting the NOD mouse to be included in a general model (Figure 1) integrating neuroendocrine and immunological defects that lead to autoimmune diabetes. Finally, this report once again raises the question of the tissue specificity of autoimmunity in mice and humans. Particularly, additional studies will be needed to reconcile the fact that the principal target of autoimmunity remains the pancreatic islet in unmanipulated NOD mice despite strong evidence of the implication of the nervous system in this process.
